EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Serum calprotectin elevation and interferon-α-induced neutrophil priming in macrophage activation syndrome associated with systemic lupus erythematosus: Clinical and experimental insights

Yohei Hosokawa iD, Yusuke Yoshida iD, Sho Mokuda iD, Naoya Oka iD, Hiroki Kobayashi iD, Genki Kidoguchi iD, Michinori Ishitoku iD, Tomohiro Sugimoto iD, Shintaro Hirata iD

Modern Rheumatology · 2026

DOI: 10.1093/mr/roag012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Rheumatology, 2026. Verfasst von Yohei Hosokawa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan. Hauptthemen laut MEDLINE: Macrophage Activation Syndrome, Lupus Erythematosus, Systemic, Leukocyte L1 Antigen Complex, Interferon-alpha. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: JSPS KAKENHI, Tsuchiya Memorial Medical Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To clarify the diagnostic utility of serum calprotectin and gene expression in interferon (IFN)-α-activated neutrophils in macrophage activation syndrome (MAS) in patients with systemic lupus erythematosus (SLE).

Methods

This single-centre, cross-sectional study analysed serum calprotectin levels in 47 patients with SLE (including eight with MAS) and 7 patients with adult-onset Still’s disease (AOSD) complicated with MAS as a reference population. In neutrophil-based experiments, mRNA expression levels of S100A8 and S100A9 were measured following stimulation with IFN-α or interleukin (IL)-1β.

Results

Serum calprotectin levels were significantly elevated in patients with SLE-MAS compared to those with SLE without MAS and comparable to those in patients with AOSD-MAS. Calprotectin levels correlated with serum ferritin levels (rs = 0.49, P = .004), but not with anti-dsDNA antibodies or complement levels. At a cut-off value of 9184.4 ng/ml, serum calprotectin demonstrated sensitivity of 62.5% and specificity of 94.9% for identifying MAS. Recombinant IFN-α2a induced a dose-dependent increase in S100A8 and S100A9 expression in neutrophils, whereas recombinant interleukin-1β had no effect. Pre-treatment with an anti-IFN-α2 neutralising antibody effectively suppressed the IFN-α2a-induced expression of S100A8 and S100A9.

Conclusions

Serum calprotectin, upregulated by IFN-α, may serve as a useful biomarker for diagnosing MAS in SLE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macrophage Activation SyndromeLupus Erythematosus, SystemicLeukocyte L1 Antigen ComplexInterferon-alphaNeutrophilsHumansFemaleAdultMaleCross-Sectional StudiesMiddle AgedCalgranulin ACalgranulin BBiomarkersNeutrophil ActivationYoung AdultInterleukin-1beta

Stichwörter der Autor:innen

Biomarkersinterferonsmacrophage activation syndromeneutrophilssystemic lupus erythematosus

Substanzen

Leukocyte L1 Antigen ComplexInterferon-alphaCalgranulin ACalgranulin BS100A8 protein, humanBiomarkersS100A9 protein, humanInterleukin-1beta

Autor:innen und Institutionen

  • Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.
  • Division of Laboratory Medicine, Hiroshima University Hospital, Hiroshima, Japan.

ORCID-Profile: Yohei Hosokawa, Yusuke Yoshida, Sho Mokuda, Naoya Oka, Hiroki Kobayashi, Genki Kidoguchi, Michinori Ishitoku, Tomohiro Sugimoto, Shintaro Hirata

Förderung

  • JSPS KAKENHI
  • Tsuchiya Memorial Medical Foundation

Zitieren

APA

Hosokawa, Y., Yoshida, Y., Mokuda, S., Oka, N., Kobayashi, H., Kidoguchi, G., Ishitoku, M., Sugimoto, T., & Hirata, S. (2026). Serum calprotectin elevation and interferon-α-induced neutrophil priming in macrophage activation syndrome associated with systemic lupus erythematosus: Clinical and experimental insights. Modern Rheumatology. https://doi.org/10.1093/mr/roag012

Vancouver

Hosokawa Y, Yoshida Y, Mokuda S, Oka N, Kobayashi H, Kidoguchi G, et al. Serum calprotectin elevation and interferon-α-induced neutrophil priming in macrophage activation syndrome associated with systemic lupus erythematosus: Clinical and experimental insights. Modern Rheumatology. 2026. doi:10.1093/mr/roag012

BibTeX
@article{Hosokawa2026,
  author = {Hosokawa, Yohei and Yoshida, Yusuke and Mokuda, Sho and Oka, Naoya and Kobayashi, Hiroki and Kidoguchi, Genki and Ishitoku, Michinori and Sugimoto, Tomohiro and Hirata, Shintaro},
  title = {Serum calprotectin elevation and interferon-α-induced neutrophil priming in macrophage activation syndrome associated with systemic lupus erythematosus: Clinical and experimental insights},
  journal = {Modern Rheumatology},
  year = {2026},
  doi = {10.1093/mr/roag012}
}
Kostenlos starten →